Synthesis of kojic acid derivatives as secondary binding site probes of d-amino acid oxidase
摘要:
A series of kojic acid (5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) derivatives were synthesized and tested for their ability to inhibit D-amino acid oxidase (DAAO). Various substituents were incorporated into kojic acid at its 2-hydroxymethyl group. These analogs serve as useful molecular probes to explore the secondary binding site, which can be exploited in designing more potent DAAO inhibitors. (c) 2013 Elsevier Ltd. All rights reserved.
Asymmetric Michael addition between kojic acid derivatives and unsaturated ketoesters promoted by <i>C</i><sub>2</sub>-symmetric organocatalysts
作者:Alexey A. Kostenko、Alexander S. Kucherenko、Andrey N. Komogortsev、Boris V. Lichitsky、Sergei G. Zlotin
DOI:10.1039/c8ob02523a
日期:——
An efficient sterically hindered C2-symmetric bifunctionaltertiary amine–squaramide organocatalyst for the asymmetric Michaeladdition/hemiketalization domino reaction of kojic acid derivatives with β,γ-unsaturated α-ketoesters has been designed. Pharmacology-relevant functionalized 2,3,4,8-tetrahydropyrano[3,2-b]pyran derivatives were produced over the catalyst in as low as 1 mol% with up to 99%
设计了一种高效的位阻C 2对称双官能叔胺-方酰胺有机催化剂,用于曲酸衍生物与β,γ-不饱和α-酮酸酯的不对称迈克尔加成/半缩酮化多米诺反应。在催化剂上以低至1 mol%的产率制备了药理学相关的官能化2,3,4,8-四氢吡喃并[3,2- b ]吡喃衍生物,产率高达99%,ee高达99%。该程序至少可扩展30倍,并且该催化剂可通过酸碱萃取容易地用于催化反应中。用(S)-或rac酰化产物-布洛芬和十一碳烯酸与相应的手性酯含有两个特权药效基序。
Organocatalytic Asymmetric Double Addition of Kojic Acids to 2‐Nitroallylic Carbonates
作者:Ruslan A. Kovalevsky、Maxim V. Smirnov、Alexander S. Kucherenko、Kseniya A. Bykova、Elizaveta V. Shikina、Sergei G. Zlotin
DOI:10.1002/ejoc.202101435
日期:2022.1.21
Chiral nitrocompounds containing two hydroxypyranone units were enantioselectively produced from kojic acid derivatives and 2-nitroallylic carbonates in the presence of bifunctional tertiary amine-squaramide organocatalyst. The reaction products were converted to corresponding acetates and nitro glutarates via acylation or oxidative fragmentation reactions.
Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor
作者:Patrick R. Maloney、Pasha Khan、Michael Hedrick、Palak Gosalia、Monika Milewski、Linda Li、Gregory P. Roth、Eduard Sergienko、Eigo Suyama、Eliot Sugarman、Kevin Nguyen、Alka Mehta、Stefan Vasile、Ying Su、Derek Stonich、Hung Nguyen、Fu-Yue Zeng、Arianna Mangravita Novo、Michael Vicchiarelli、Jena Diwan、Thomas D.Y. Chung、Layton H. Smith、Anthony B. Pinkerton
DOI:10.1016/j.bmcl.2012.08.105
日期:2012.11
The recently discovered apelin/APJ system has emerged as a critical mediator of cardiovascular homeostasis and is associated with the pathogenesis of cardiovascular disease. A role for apelin/APJ in energy metabolism and gastrointestinal function has also recently emerged. We disclose the discovery and characterization of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221), a potent APJ functional antagonist in cell-based assays that is >37-fold selective over the closely related angiotensin II type 1 (AT1) receptor. ML221 was derived from an HTS of the similar to 330,600 compound MLSMR collection. This antagonist showed no significant binding activity against 29 other GPCRs, except to the kappa-opioid and benzodiazepinone receptors (<50/<70%I at 10 mu M). The synthetic methodology, development of structure-activity relationship (SAR), and initial in vitro pharmacologic characterization are also presented. (C) 2012 Elsevier Ltd. All rights reserved.